Literature DB >> 16121604

Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States.

Eric J Neumann1, James B Kliebenstein, Colin D Johnson, John W Mabry, Eric J Bush, Ann H Seitzinger, Alice L Green, Jeffrey J Zimmerman.   

Abstract

OBJECTIVE: To estimate the annual cost of infections attributable to porcine reproductive and respiratory syndrome (PRRS) virus to US swine producers.
DESIGN: Economic analysis. SAMPLE POPULATION: Data on the health and productivity of PRRS-affected and PRRS-unaffected breeding herds and growing-pig populations were collected from a convenience sample of swine farms in the midwestern United States. PROCEDURE: Health and productivity variables of PRRS-affected and PRRS-unaffected swine farms were analyzed to estimate the impact of PRRS on specific farms. National estimates of PRRS incidence were then used to determine the annual economic impact of PRRS on US swine producers.
RESULTS: PRRS affected breeding herds and growing-pig populations as measured by a decrease in reproductive health, an increase in deaths, and reductions in the rate and efficiency of growth. Total annual economic impact of these effects on US swine producers was estimated at dollar 66.75 million in breeding herds and dollar 493.57 million in growing-pig populations. CONCLUSIONS AND CLINICAL RELEVANCE: PRRS imposes a substantial financial burden on US swine producers and causes approximately dollar 560.32 million in losses each year. By comparison, prior to eradication, annual losses attributable to classical swine fever (hog cholera) and pseudorabies were estimated at dollar 364.09 million and dollar 36.27 million, respectively (adjusted on the basis of year 2004 dollars). Current PRRS control strategies are not predictably successful; thus, PRRS-associated losses will continue into the future. Research to improve our understanding of ecologic and epidemiologic characteristics of the PRRS virus and technologic advances (vaccines and diagnostic tests) to prevent clinical effects are warranted.

Entities:  

Mesh:

Year:  2005        PMID: 16121604     DOI: 10.2460/javma.2005.227.385

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  316 in total

1.  Porcine reproductive and respiratory syndrome virus infection at the time of porcine circovirus type 2 vaccination has no impact on vaccine efficacy.

Authors:  A Sinha; H G Shen; S Schalk; N M Beach; Y W Huang; P G Halbur; X J Meng; T Opriessnig
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

2.  Utility of a panviral microarray for detection of swine respiratory viruses in clinical samples.

Authors:  Tracy L Nicholson; Deborah Kukielka; Amy L Vincent; Susan L Brockmeier; Laura C Miller; Kay S Faaberg
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

3.  Arterivirus and nairovirus ovarian tumor domain-containing Deubiquitinases target activated RIG-I to control innate immune signaling.

Authors:  Puck B van Kasteren; Corrine Beugeling; Dennis K Ninaber; Natalia Frias-Staheli; Sander van Boheemen; Adolfo García-Sastre; Eric J Snijder; Marjolein Kikkert
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

4.  Complete genome sequence of porcine reproductive and respiratory syndrome virus isolated from piglet stool samples.

Authors:  Tao Song; Liurong Fang; Songlin Zeng; Bin Li; Huanchun Chen; Shaobo Xiao
Journal:  J Virol       Date:  2012-04       Impact factor: 5.103

5.  Molecular epidemiological investigation of porcine reproductive and respiratory syndrome virus in Northwest China from 2007 to 2010.

Authors:  Youjun Shang; Guangxiang Wang; Hong Tian; Shuanghui Yin; Ping Du; Jinyan Wu; Yan Chen; Shunli Yang; Ye Jin; Keshan Zhang; Xiangtao Liu
Journal:  Virus Genes       Date:  2012-06-23       Impact factor: 2.332

6.  The cysteine protease domain of porcine reproductive and respiratory syndrome virus nonstructural protein 2 possesses deubiquitinating and interferon antagonism functions.

Authors:  Zhi Sun; Zhenhai Chen; Steven R Lawson; Ying Fang
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

7.  Development of a chimeric strain of porcine reproductive and respiratory syndrome virus with an infectious clone and a Korean dominant field strain.

Authors:  Jung-Ah Lee; Nak-Hyung Lee; Sang-Won Lee; Seung-Yong Park; Chang-Seon Song; In-Soo Choi; Joong-Bok Lee
Journal:  J Microbiol       Date:  2014-03-29       Impact factor: 3.422

8.  A full-length cDNA infectious clone of North American type 1 porcine reproductive and respiratory syndrome virus: expression of green fluorescent protein in the Nsp2 region.

Authors:  Ying Fang; Raymond R R Rowland; Michael Roof; Joan K Lunney; Jane Christopher-Hennings; Eric A Nelson
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

9.  Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5.

Authors:  Jung-Ah Lee; Byungjoon Kwon; Fernando A Osorio; Asit K Pattnaik; Nak-Hyung Lee; Sang-Won Lee; Seung-Yong Park; Chang-Seon Song; In-Soo Choi; Joong-Bok Lee
Journal:  Vaccine       Date:  2014-05-09       Impact factor: 3.641

10.  Identification of Nonstructural Protein 8 as the N-Terminus of the RNA-Dependent RNA Polymerase of Porcine Reproductive and Respiratory Syndrome Virus.

Authors:  Yuanyuan Liu; Yunhao Hu; Yue Chai; Liping Liu; Jiangwei Song; Shaochuan Zhou; Jia Su; Lei Zhou; Xinna Ge; Xin Guo; Jun Han; Hanchun Yang
Journal:  Virol Sin       Date:  2018-10-23       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.